Aberdeen Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
256,040
-24,694
| -9% | -$1.7M | 0.03% | 448 |
|
|
2025
Q1 | $19.5M | Buy |
280,734
+20,565
| +8% | +$1.43M | 0.04% | 394 |
|
|
2024
Q4 | $22.3M | Buy |
260,169
+27,784
| +12% | +$2.38M | 0.04% | 346 |
|
|
2024
Q3 | $27.7M | Sell |
232,385
-8,999
| -4% | -$1.07M | 0.05% | 317 |
|
|
2024
Q2 | $34.5M | Buy |
241,384
+73
| +0% | +$10.4K | 0.07% | 271 |
|
|
2024
Q1 | $31M | Buy |
241,311
+13,679
| +6% | +$1.76M | 0.06% | 295 |
|
|
2023
Q4 | $23.5M | Buy |
+227,632
| New | +$23.5M | 0.05% | 349 |
|